Assessment of l-Asparaginase Pharmacodynamics in Mouse Models of Cancer

Area of Science:

• Biochemistry
• Pharmacology
• Analytical Chemistry

Background:

• l-asparaginase (ASNase) is a key anti-cancer drug for acute lymphoblastic leukemia (ALL).
• ASNase works by depleting asparagine (Asn) and glutamine (Gln), essential for cancer cell survival.
• Accurate in vivo pharmacodynamic (PD) assessment of ASNase is difficult due to enzyme stability, high catalytic efficiency, and ex vivo analyte depletion.

Purpose of the Study:

• To develop a novel bioanalytical method for precise measurement of ASNase's pharmacodynamics.
• To enable longitudinal studies of ASNase PD in individual animals.
• To facilitate the optimization of ASNase treatment strategies and development of new ASNase variants.

Main Methods:

• A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed.
• The method incorporates rapid quenching to prevent ex vivo degradation of analytes.
• Quantification of Asn, aspartic acid (Asp), Gln, and glutamic acid (Glu) in small volumes (10 µL) of whole blood.

Main Results:

• The method achieved low limits of detection for Asn (2.3 µM), Asp (3.5 µM), Gln (0.8 µM), and Glu (0.5 µM).
• The method demonstrated simplicity, accuracy, and precision in a 5-day longitudinal mouse study.
• Successfully enabled dense data acquisition from individual animals for PD analysis.

Conclusions:

• The developed LC-MS/MS method effectively overcomes challenges in measuring ASNase PD.
• This tool enhances the ability to study ASNase's effects in vivo.
• It will be instrumental in refining current ALL therapies and developing improved ASNase-based treatments.